BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 30482505)

  • 1. Simultaneous integrated boost by Intensity Modulated Radiotherapy (SIB-IMRT) in patients undergoing breast conserving surgery - A clinical and dosimetric perspective.
    Dewan A; Chufal KS; Dewan AK; Pahuja A; Mehrotra K; Singh R; Chaudhary RL; Suresh T; Mishra M; Sundari AV; Bommera S; Narang R; Pathak P; Mitra S; Sharma SK; Gairola M
    J Egypt Natl Canc Inst; 2018 Dec; 30(4):165-171. PubMed ID: 30482505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated hypofractionated adjuvant whole breast radiation with simultaneous integrated boost using volumetric modulated arc therapy for early breast cancer: A phase I/II dosimetric and clinical feasibility study from a tertiary cancer care centre of India.
    Mondal D; Julka PK; Sharma DN; Jana M; Laviraj MA; Deo SV; Roy S; Guleria R; Rath GK
    J Egypt Natl Canc Inst; 2017 Mar; 29(1):39-45. PubMed ID: 28343538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant breast inversely planned intensity-modulated radiotherapy with simultaneous integrated boost for early stage breast cancer : Results from a phase II trial.
    Meng J; Huang W; Mei X; Yu X; Pan Z; Ma J; Ma X; Chen J; Guo X; Yang Z
    Strahlenther Onkol; 2020 Sep; 196(9):764-770. PubMed ID: 32318767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-year results of whole breast intensity modulated radiation therapy for the treatment of early stage breast cancer: the Fox Chase Cancer Center experience.
    Keller LM; Sopka DM; Li T; Klayton T; Li J; Anderson PR; Bleicher RJ; Sigurdson ER; Freedman GM
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):881-7. PubMed ID: 22909414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments.
    Scorsetti M; Alongi F; Fogliata A; Pentimalli S; Navarria P; Lobefalo F; Garcia-Etienne C; Clivio A; Cozzi L; Mancosu P; Nicolini G; Vanetti E; Eboli M; Rossetti C; Rubino A; Sagona A; Arcangeli S; Gatzemeier W; Masci G; Torrisi R; Testori A; Alloisio M; Santoro A; Tinterri C
    Radiat Oncol; 2012 Aug; 7():145. PubMed ID: 22929062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decline of cosmetic outcomes following accelerated partial breast irradiation using intensity modulated radiation therapy: results of a single-institution prospective clinical trial.
    Liss AL; Ben-David MA; Jagsi R; Hayman JA; Griffith KA; Moran JM; Marsh RB; Pierce LJ
    Int J Radiat Oncol Biol Phys; 2014 May; 89(1):96-102. PubMed ID: 24613813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensity modulated radiation therapy with simultaneous integrated boost in early breast cancer irradiation. Report of feasibility and preliminary toxicity.
    Fiorentino A; Mazzola R; Ricchetti F; Giaj Levra N; Fersino S; Naccarato S; Sicignano G; Ruggieri R; Di Paola G; Massocco A; Gori S; Alongi F
    Cancer Radiother; 2015 Aug; 19(5):289-94. PubMed ID: 26206732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensity Modulated Radiation Therapy (IMRT) With Simultaneously Integrated Boost Shortens Treatment Time and Is Noninferior to Conventional Radiation Therapy Followed by Sequential Boost in Adjuvant Breast Cancer Treatment: Results of a Large Randomized Phase III Trial (IMRT-MC2 Trial).
    Hörner-Rieber J; Forster T; Hommertgen A; Haefner MF; Arians N; König L; Harrabi SB; Schlampp I; Weykamp F; Lischalk JW; Heinrich V; Weidner N; Hüsing J; Sohn C; Heil J; Hof H; Krug D; Debus J
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1311-1324. PubMed ID: 33321192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypofractionated Simultaneous Integrated Boost Radiotherapy Versus Conventional Fractionation Radiotherapy of Early Breast Cancer After Breast-Conserving Surgery: Clinical Observation and Analysis.
    Dong J; Yang Y; Han D; Zhao Q; Liu C; Sun H; Wang Z; Lin H; Huang W
    Technol Cancer Res Treat; 2021; 20():15330338211064719. PubMed ID: 34898315
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypofractionation with simultaneous boost in breast cancer patients receiving adjuvant chemotherapy: A prospective evaluation of a case series and review of the literature.
    De Rose F; Fogliata A; Franceschini D; Iftode C; Navarria P; Comito T; Franzese C; Fernandes B; Masci G; Torrisi R; Tinterri C; Testori A; Santoro A; Scorsetti M
    Breast; 2018 Dec; 42():31-37. PubMed ID: 30149235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensity modulated radiotherapy with simultaneous integrated boost vs. conventional radiotherapy with sequential boost for breast cancer - A preliminary result.
    Lee HH; Hou MF; Chuang HY; Huang MY; Tsuei LP; Chen FM; Ou-Yang F; Huang CJ
    Breast; 2015 Oct; 24(5):656-60. PubMed ID: 26371691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated partial breast irradiation is safe and effective using intensity-modulated radiation therapy in selected early-stage breast cancer.
    Lewin AA; Derhagopian R; Saigal K; Panoff JE; Abitbol A; Wieczorek DJ; Mishra V; Reis I; Ferrell A; Moreno L; Takita C
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2104-10. PubMed ID: 21640490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbidities and intensity-modulated radiotherapy with simultaneous integrated boost in elderly breast cancer patients.
    Fiorentino A; Mazzola R; Giaj Levra N; Fersino S; Ricchetti F; Di Paola G; Gori S; Massocco A; Alongi F
    Aging Clin Exp Res; 2018 May; 30(5):533-538. PubMed ID: 28755327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypofractionated Breast Radiation: Shorter Scheme, Lower Toxicity.
    Linares I; Tovar MI; Zurita M; Guerrero R; Expósito M; Del Moral R
    Clin Breast Cancer; 2016 Aug; 16(4):262-8. PubMed ID: 26454613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant breast radiotherapy using a simultaneous integrated boost: clinical and dosimetric perspectives.
    Alford SL; Prassas GN; Vogelesang CR; Leggett HJ; Hamilton CS
    J Med Imaging Radiat Oncol; 2013 Apr; 57(2):222-9. PubMed ID: 23551785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Outcomes Using Hypofractionated Tumor Bed Boost Combined With Hypofractionated Whole Breast Irradiation for Early-stage Breast Cancer.
    Yu E; Huang D; Leonard K; Dipetrillo T; Wazer D; Hepel J
    Clin Breast Cancer; 2017 Dec; 17(8):638-643. PubMed ID: 28629952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I/II study piloting accelerated partial breast irradiation using CT-guided intensity modulated radiation therapy in the prone position.
    Bergom C; Prior P; Kainz K; Morrow NV; Ahunbay EE; Walker A; Allen Li X; White J
    Radiother Oncol; 2013 Aug; 108(2):215-9. PubMed ID: 23932158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous integrated boost irradiation after breast-conserving surgery: physician-rated toxicity and cosmetic outcome at 30 months' follow-up.
    Bantema-Joppe EJ; Schilstra C; de Bock GH; Dolsma WV; Busz DM; Langendijk JA; Maduro JH
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e471-7. PubMed ID: 22494592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Accelerated partial breast irradiation with image-guided intensity-modulated radiotherapy following breast-conserving surgery - preliminary results of a phase II clinical study].
    Mészáros N; Major T; Stelczer G; Zaka Z; Mózsa E; Fodor J; Polgár C
    Magy Onkol; 2015 Jun; 59(2):111-8. PubMed ID: 26035158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypofractionated Whole Breast Irradiation and Simultaneous Integrated Boost in Large-breasted Patients: Long-term Toxicity and Cosmesis.
    De Rose F; Fogliata A; Franceschini D; Iftode C; D'Agostino GR; Comito T; Franzese C; Di Brina L; Clerici E; Loi M; Navarria P; Gatzemeier W; Testori A; Tinterri C; Lobefalo F; Tomatis S; Cozzi L; Scorsetti M
    Clin Breast Cancer; 2020 Dec; 20(6):527-533. PubMed ID: 32665192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.